Conventus Orthopaedics’ DRS Implant Receives FDA Clearance

Conventus Orthopaedics has received FDA 510(k) clearance for its Conventus DRS Implant to treat distal radius fractures.

Advertisement

The implant is designed to be less invasive for orthopedic surgeons, according to the release. Surgeons can treat a bread range of distal radius fractures without sacrificing stability.

The device also underwent a clinical study in Europe.

More Articles on Devices:
Johnson & Johnson’s Synthes Acquisition Adds 5.6% 4Q Sales Growth
Stryker Reports 4.2% Net Sales Growth in 2012, Hampered by $133M in Recall Charges
Smith & Nephew Wound Device Could Lower Healthcare Costs

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.